Segrow Bio-Technics (India) Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 03-07-2024
- Paid Up Capital ₹ 1.46 Cr
as on 03-07-2024
- Company Age 35 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -56.66%
(FY 2021)
- Profit -333.99%
(FY 2021)
- Ebitda 28.53%
(FY 2021)
- Net Worth -54.96%
(FY 2021)
- Total Assets -3.63%
(FY 2021)
About Segrow Bio-Technics (India)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gokul Patnaik and Ramesh Vangal serve as directors at the Company.
- CIN/LLPIN
U01122DL1989PTC038321
- Company No.
038321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Segrow Bio-Technics (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Vangal  | Director | 09-Nov-1989 | Current |
Gokul Patnaik  | Director | 14-Aug-2000 | Current |
Financial Performance and Corporate Structure Insights of Segrow Bio-Technics (India).
Segrow Bio-Technics (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 56.66% decrease. The company also saw a substantial fall in profitability, with a 333.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Segrow Bio-Technics (India)?
In 2022, Segrow Bio-Technics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Katra Phytochem (India) Private LimitedActive 28 years 4 monthsGokul Patnaik and Ramesh Vangal are mutual person
Ayurvedagram Heritage Wellness Centre Private LimitedActive 21 years 10 monthsRamesh Vangal is a mutual person
- Global Agri System Private LimitedActive 26 years 11 months
Gokul Patnaik and Ramesh Vangal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Segrow Bio-Technics (India)?
Unlock and access historical data on people associated with Segrow Bio-Technics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Segrow Bio-Technics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Segrow Bio-Technics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
